Envoy Medical, Inc.

Anzu Special Acquisition Corp I, trading under the ticker ANZU, is a blank-check company that completed its initial public offering in 2021 and filed a 10-Q with the SEC on May 17, 2021 under the associated entity name Envoy Medical, Inc. The SPAC was sponsored by Anzu Partners and focused on the healthcare and medical technology sector, with Envoy Medical Corporation — a Minnesota-based developer of fully implantable hearing devices — identified as the target business combination. The filing reflects the company's status as a special purpose acquisition vehicle during its search and transaction phase. For full filing history, sponsor details, deal timelines, and SPAC analytics on ANZU and hundreds of other vehicles, sign up for complete data access at SpacDesk.